Status:
COMPLETED
Programed Intermittent Epidural Bolus Interval 90 (EI90) of 10 ml, 0.0625% Bupivacaine Plus 2 μg/mL Fentanyl
Lead Sponsor:
Menoufia University
Conditions:
Labour Pain
Eligibility:
FEMALE
Up to 50 years
Phase:
NA
Brief Summary
Multiple studies showed the numerous advantages of implementing programmed epidural bolus (PIEB) technique, where a fixed volume of local anesthetic is automatically administrated at a set time interv...
Eligibility Criteria
Inclusion
- Patients of ASA physical status 2-3 with a singleton pregnancy
- gestational age \> 37 weeks
- regular uterine contractions occurring at least every 5 min;
- cervical dilation 2-5 cm
- pain \> 5 (Visual analogue score (VAS) 0-10) at the time of request for epidural analgesia .
Exclusion
- Refusal to concent
- Contraindication to epidural analgesia as allergy or hypersensitivity to bupivacaine or fentanyl
- Patients who had opioids or sedatives within 4 h preceding epidural insertion.
- Unintentional dural puncture.
- Patient who deliver within 1 h after initiation of epidural clinician bolus.
- The inability to achieve as VAS score ≤2 after the initial loading dose will be considered as a failure and will be excluded from the study.
Key Trial Info
Start Date :
November 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 20 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05441085
Start Date
November 1 2022
End Date
November 20 2023
Last Update
August 30 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine Menoufia University
Cairo, Governorate, Egypt, 32511
2
Rabab Habeeb
Cairo, Governorate, Egypt, 32817